India has emerged as a global hub for pharmaceutical research, manufacturing, and outsourcing services.

Among the many players in the industry, Contract Development and Manufacturing Organizations (CDMOs) are transforming how pharmaceutical companies operate by providing end-to-end services that range from drug development to commercial-scale manufacturing.

With a strong B2B model, global regulatory compliance, and a robust product pipeline, Biodeal Pharmaceuticals is positioned to grow its CDMO segment significantly.

The Indian CDMO market is expected to more than double by 2030, driven by rising global outsourcing, supply chain diversification, and technological advancements.

Indian CDMO companies are positioned for significant growth over the next decade, supported by competitive pricing, skilled talent and regulatory compliance.

Pharma companies are rapidly expanding capabilities in biologics and complex drug manufacturing.

As the sector evolves, India’s role as a preferred CDMO industrial hub is set to strengthen, solidifying its position as a powerhouse in global drug development and manufacturing.

Biodeal Pharmaceuticals Limited is a leading Contract Development & Manufacturing Organization (CDMO) in India, serving over 600 clients worldwide. With our WHO-GMP & PIC/S-certified facilities based in Nalagarh, Himachal Pradesh, we provide end-to-end pharmaceutical manufacturing solutions that meet the highest global quality standards.

Core Expertise:

• Solid orals: Tablets, Capsules (including modified-release)

• Nasal sprays – including

• Dry Powder Inhalers (DPI)

• Pediatric & adult probiotics

• Herbal & nutraceuticals (new advanced facility)

• Topical formats, oral sprays, hygiene solutions

 Why Partner with Biodeal?

• Advanced R&D and analytical labs

• Regulatory-compliant (WHO-GMP, FSSAI, PIC/S)

• Trusted by India’s top 20 pharma giants

• End-to-end CDMO & private-label services

We specialize in pharma third-party manufacturing, private-label launches, and custom formulation development across therapeutic areas including infectious diseases, pediatrics, ENT, CNS, and more.

 Ready to collaborate?

Let’s build your next pharma success story